piribedil has been researched along with Ischemic Attack, Transient in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dechaume, JP | 1 |
| Lecuire, J | 1 |
| Fourcade, C | 1 |
| El Quarzazi, A | 1 |
| Rossi, A | 1 |
1 other study available for piribedil and Ischemic Attack, Transient
| Article | Year |
|---|---|
[Clinical and pharmacological studies on a therapy of cerebral ischemia in neurosurgical practice].
Topics: Adult; Aged; Animals; Brain; Brain Edema; Brain Injuries; Brain Neoplasms; Cerebrovascular Circulati | 1976 |